These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6014433)

  • 1. [Interference of the central antichloinergic effect in experimental animal tests of potential antidepressives].
    Schaumann W; Ribbentrop A
    Arzneimittelforschung; 1966 May; 16(5):646-9. PubMed ID: 6014433
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basic tricyclic oxyiminoethers and their pharmacological properties].
    Aichinger G; Behner O; Hoffmeister F; Schütz S
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:838+. PubMed ID: 5819763
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral effects of methamphetamine and -methyltyrosine in the rat.
    Evans HL
    J Pharmacol Exp Ther; 1971 Jan; 176(1):244-54. PubMed ID: 5569634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relations between anorexigenic effect and fatty acid mobilization by methamphetamine].
    Falb A; Schmidt G; Schwabe U
    Arzneimittelforschung; 1966 Jun; 16(6):733-4. PubMed ID: 6014583
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug interference and incompatibilities of drugs attacking the central nervous system. 2. Stimulants].
    Estler CJ
    Fortschr Med; 1973 May; 91(13):574-6. PubMed ID: 4701126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1045-59. PubMed ID: 5145608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological research in the diphenylcarbamic acid thio ester series. II].
    Wirth W; Gösswald R
    Arch Int Pharmacodyn Ther; 1965 Jun; 155(2):393-417. PubMed ID: 5891500
    [No Abstract]   [Full Text] [Related]  

  • 10. Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.
    Scheel-Krüger J
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):1-16. PubMed ID: 5467751
    [No Abstract]   [Full Text] [Related]  

  • 11. Central nervous system activity of 1-(3-methoxypropylamino)-2-hydroxy-2-(1,4-benzodioxan-2-yl)-ethane hydrochloride.
    Cestari A; Babbini M; De Marchi F; Graziani G
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):167-80. PubMed ID: 6069043
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative quantitative studies on cholinolytics. 3. The action of propanteline, methanteline, oxyphenonium and diphemanil.
    Wilimowski M; Orzechowska K; Prandota J; Barczyńska J
    Arch Immunol Ther Exp (Warsz); 1970; 18(1):139-42. PubMed ID: 4392419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some indices of effect of acridine orange and proflavine on the central nervous system].
    Mashkovskiĭ MD; Polezhaeva AI
    Farmakol Toksikol; 1969; 32(1):25-8. PubMed ID: 5814163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the central action of amantadine].
    Florio V
    Farmaco Prat; 1971 Nov; 26(11):648-58. PubMed ID: 5157778
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of delta-tetrahydrocannabinol with barbiturates and methamphetamine.
    Kubena RK; Barry H
    J Pharmacol Exp Ther; 1970 May; 173(1):94-100. PubMed ID: 5442307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 3-indolylacetylaminorhodanine on the central nervous system of albino rats].
    Nevelichuk VV
    Farmakol Toksikol; 1967; 30(4):401-2. PubMed ID: 5598886
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of haloperidol on the central nervous system].
    Vinogradov VV; Krylov SS; Snegirev EA; Sysoeva AF; Khasabova VA
    Farmakol Toksikol; 1967; 30(2):131-4. PubMed ID: 4971063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research advances in central nervous system effects of scopolamine and related compounds (author's transl)].
    Bian CF; Wang JH
    Sheng Li Ke Xue Jin Zhan; 1981 Feb; 12(2):139-45. PubMed ID: 7031892
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology of a potential anti-Parkinson agent: tigloidine.
    Sanghvi I; Bindler E; Gershon S
    Eur J Pharmacol; 1968 Oct; 4(3):246-53. PubMed ID: 5723419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.